Latest News

British Organization - May 3

The following are the leading stories on the business pages of British newspapers. has not validated these stories and does not guarantee their precision.

The Times

- Coutts, the private bank owned by Britain's NatWest , has actually been implicated of adding to the UK's problems by switching practically 2 billion stg ($ 2.51 billion) of client money out of the London stock exchange to invest overseas.

- Hundreds of investment bankers at Goldman Sachs in London are to have their pay bundles upgraded after the Wall Street huge told staff that it would ditch caps on bonus offers, ending up being the first big lending institution in the UK to announce the modification.

The Guardian

- Nonrenewable fuel source companies will be allowed to check out for oil and gas under offshore wind-power sites for the very first time, the federal government will reveal on Friday, in a relocation that advocates said is additional proof that ministers are abandoning the climate agenda.

- More than 10,500 of London's black-cab drivers have launched a 250 million stg ($ 313.80 million) legal case versus Uber, implicating it of breaking the capital's taxi booking rules and deliberately misleading authorities to protect a. license.

The Telegraph

- London's beleaguered stock market is set for an uncommon increase. as Unique Opportunities REIT, a recently established realty. financial investment trust prepares to introduce a 500 million stg ($ 627.60. million) listing in June.

- The Guardian has launched a redundancy programme for its. UK-based editorial personnel as the newspaper grapples with a sharp. downturn in marketing and looks for to cut expenses.

Sky News

- Business payments comparison website Tuza has secured 4. million stg ($ 5.02 million) of seed capital from financiers. including Link Ventures and Northzone, an early investor in. Spotify.

The Independent

- A brand-new treatment for sickle cell illness is set to be. rolled out across the UK following a successful, patient-led. appeal making it the very first sickle cell treatment to be. suggested by the National Institute for Health and Care. Excellence for regular use on the NHS.